{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-016378","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.278065+00:00","generated_at":"2026-05-16T02:24:30.409862+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Coherus Oncology closes $47M public offering of 28.6M shares at $1.75/share","bullets":["Issued 28.6M common shares at $1.75 public price; underwriters paid $1.645/share.","Net proceeds of ~$47.0M after underwriting discounts and commissions.","Underwriters have 30-day option to purchase up to 4.29M additional shares for over-allotments.","Directors, officers, and certain stockholders subject to 60-day lock-up agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-016378","json":"https://secwatch.observer/filing/0001104659-26-016378.json","markdown":"https://secwatch.observer/filing/0001104659-26-016378.md","text":"https://secwatch.observer/filing/0001104659-26-016378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926016378/0001104659-26-016378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926016378/chrs-20260212x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:24:30.409862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}